Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
22.82
+0.15 (0.66%)
Jun 3, 2025, 1:24 PM - Market open
Cidara Therapeutics Market Cap
Cidara Therapeutics has a market cap or net worth of $295.91 million as of June 3, 2025. Its market cap has increased by 410.18% in one year.
Market Cap
295.91M
Enterprise Value
128.48M
1-Year Change
410.18%
Ranking
Category
Stock Price
$22.82
Market Cap Chart
Since April 15, 2015, Cidara Therapeutics's market cap has increased from $203.10M to $295.91M, an increase of 45.69%. That is a compound annual growth rate of 3.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2025 | 294.00M | 55.23% |
| Dec 31, 2024 | 189.40M | 163.79% |
| Dec 29, 2023 | 71.80M | 32.47% |
| Dec 30, 2022 | 54.20M | -36.01% |
| Dec 31, 2021 | 84.70M | -3.64% |
| Dec 31, 2020 | 87.90M | -30.73% |
| Dec 31, 2019 | 126.90M | 94.63% |
| Dec 31, 2018 | 65.20M | -52.62% |
| Dec 29, 2017 | 137.60M | -20.65% |
| Dec 30, 2016 | 173.40M | -26.34% |
| Dec 31, 2015 | 235.40M | 15.90% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.95B |
| Johnson & Johnson | 370.54B |
| AbbVie | 328.20B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 275.21B |
| Abbott Laboratories | 231.55B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |